Tuzun, E. Et Al. 2014. Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients. 12th International Congress of Neuroimmunology (ISNI) , (Mainz, Germany), 228.

Tuzun, E., Ulusoy, C. A., Turan, S., Orcen, A., Yetimler, B., Akbas-demir, D., ... Kucukerden, M.(2014). Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients . 12th International Congress of Neuroimmunology (ISNI) (pp.228). Mainz, Germany

Tuzun, Erdem Et Al. "Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients," 12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 2014

Tuzun, Erdem Et Al. "Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients." 12th International Congress of Neuroimmunology (ISNI) , Mainz, Germany, pp.228, 2014

Tuzun, E. Et Al. (2014) . "Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients." 12th International Congress of Neuroimmunology (ISNI) , Mainz, Germany, p.228.

@conferencepaper{conferencepaper, author={Erdem TÜZÜN Et Al. }, title={Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients}, congress name={12th International Congress of Neuroimmunology (ISNI)}, city={Mainz}, country={Germany}, year={2014}, pages={228} }